The differential analysis revealed that 58% of tumors showed a moderate significant increase in relative expression of Exon 9-retaining IL6R isoform (FC ≥ 1.4—p ≤ 0.05) especially for the acute myeloid leukemia displayed a FC equal to 2.53 (Table S1). This evidence concerns the gene IL6R and acute myeloid leukemia.